review Open AccessTop 1% cited

Oncology Meets Immunology: The Cancer-Immunity Cycle

Immunity · 2013 · Vol. 39(1) · pp. 1–10

Daniel S. Chen✉(Stanford University)Ira Mellman(University of California, San Francisco)

Cancer Immunotherapy and Biomarkers CAR-T cell therapy research Immunotherapy and Immune ResponsesImmune systemCancerCancer immunotherapyImmunotherapyBiologyImmunologyTumor microenvironmentAutoimmunityImmunityEffector

MeSH terms

HumansImmunityImmunotherapyNeoplasmsT-LymphocytesSignal TransductionCytokinesModels, ImmunologicalTumor Microenvironment

Citations

6,760

FWCI

65.11

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

Advanced Science · 2022 · 620 citations

Immune checkpoints and their inhibition in cancer and infectious diseases

European Journal of Immunology · 2017 · 533 citations

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment

Frontiers in Immunology · 2018 · 603 citations

Journal of Clinical Investigation · 2017 · 3,763 citations

The Roles of Autophagy in Cancer

International Journal of Molecular Sciences · 2018 · 938 citations

Immune Escape Mechanisms as a Guide for Cancer Immunotherapy

Clinical Cancer Research · 2014 · 1,080 citations

T Cell Dysfunction in Cancer

Cancer Cell · 2018 · 1,287 citations

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

The Lancet Oncology · 2019 · 1,645 citations

References

The PD‐1 pathway in tolerance and autoimmunity

Immunological Reviews · 2010 · 2,263 citations

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Journal of Clinical Oncology · 2010 · 2,913 citations

Cancer immunoediting: from immunosurveillance to tumor escape

Nature Immunology · 2002 · 5,232 citations

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

New England Journal of Medicine · 2010 · 15,037 citations

SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation

The Journal of Immunology · 2004 · 1,218 citations

Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer

Clinical Cancer Research · 2005 · 994 citations

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

Molecular and Cellular Biology · 2005 · 1,889 citations

Role of the PD-1 Pathway in the Immune Response

American Journal of Transplantation · 2012 · 427 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.